Dr. Thrower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Andrew C. Carlos MS Institute Shepherd
2020 Peachtree Rd NW
Atlanta, GA 30309Phone+1 404-352-2020
Summary
- Ben Thrower, MD is a neurologist based in Atlanta, GA. He completed his medical education at the University of Florida College of Medicine in 1988 and then moved onto his internship and residency at the University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine. Dr. Thrower has a vast experience in general neurology, multiple sclerosis, and neuroimmunology. His research, particularly in multiple sclerosis, has repeatedly been published in reputable journals, and has been widely cited. Dr. Thrower has also been involved in clinical trials focused on treatments for multiple sclerosis. Dr. Thrower serves as the Medical Director of the Andrew C. Carlos MS Institute at Shepherd Center in Atlanta. He co-authored the book Navigating Life with MS and is an Associate Clinical Professor of Neurology at the AU/UGA Medical Partnership.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Neurology, 1989 - 1992
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1988 - 1989
- University of Florida College of MedicineClass of 1988
Certifications & Licensure
- GA State Medical License 2001 - 2025
- WA State Medical License 1992 - 2002
- TX State Medical License 1990 - 1992
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 1 citationsRecognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-...Ben Thrower, Scott D Newsome, Barry Hendin, Sherry Danese, Jenifer Patterson
International Journal of MS Care. 2024-03-11 - 4 citationsDemographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES tr...Mitzi J Williams, Annette F Okai, Anne H Cross, Nancy L Monson, Timothy Vartanian
Multiple Sclerosis and Related Disorders. 2023-08-01 - 9 citationsEffect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosisGuy J. Buckle, Daniel S. Bandari, Jeffrey Greenstein, Mark Gudesblatt, Bhupendra O. Khatri
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2020-04-29
Press Mentions
- How B-cell Therapy Affects MSFebruary 7th, 2023
- How Pregnancy Affects Multiple Sclerosis (MS), According to ExpertsOctober 6th, 2022
- ImStem Announces First US Multiple Sclerosis Patient Has Been Dosed with Its IMS001November 18th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: